| Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1 D Refojo, M Schweizer, C Kuehne, S Ehrenberg, C Thoeringer, AM Vogl, ... Science 333 (6051), 1903-1907, 2011 | 346 | 2011 |
| Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior A Lu, MA Steiner, N Whittle, AM Vogl, SM Walser, M Ableitner, D Refojo, ... Molecular psychiatry 13 (11), 1028-1042, 2008 | 161 | 2008 |
| Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety N Dedic, C Kühne, M Jakovcevski, J Hartmann, AJ Genewsky, KS Gomes, ... Nature neuroscience 21 (6), 803-807, 2018 | 112 | 2018 |
| MicroRNA-9 controls dendritic development by targeting REST SA Giusti, AM Vogl, MM Brockmann, CA Vercelli, ML Rein, D Trümbach, ... Elife 3, e02755, 2014 | 110 | 2014 |
| Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2 JM Deussing, J Breu, C Kühne, M Kallnik, M Bunck, L Glasl, YC Yen, ... Journal of Neuroscience 30 (27), 9103-9116, 2010 | 98 | 2010 |
| Behavioral phenotyping of Nestin-Cre mice: implications for genetic mouse models of psychiatric disorders SA Giusti, CA Vercelli, AM Vogl, AW Kolarz, NS Pino, JM Deussing, ... Journal of psychiatric research 55, 87-95, 2014 | 95 | 2014 |
| Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition AM Vogl, MM Brockmann, SA Giusti, G Maccarrone, CA Vercelli, ... Nature neuroscience 18 (2), 239-251, 2015 | 90 | 2015 |
| Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics AM Vogl, L Phu, R Becerra, SA Giusti, E Verschueren, TB Hinkle, ... Nature Structural & Molecular Biology 27 (2), 210-220, 2020 | 64 | 2020 |
| Conditional CRH overexpressing mice: an animal model for stress-elicited pathologies and treatments that target the central CRH system A Lu, MA Steiner, N Whittle, AM Vogl, SM Walser, M Ableitner, D Refojo, ... Molecular psychiatry 13 (11), 989-989, 2008 | 19 | 2008 |
| Immunology, Signal Transduction, and Behavior in Hypothalamic–Pituitary–Adrenal Axis‐related Genetic Mouse Models S Silberstein, AM Vogl, JJ Bonfiglio, W Wurst, F Holsboer, E Arzt, ... Annals of the New York Academy of Sciences 1153 (1), 120-130, 2009 | 18 | 2009 |
| Amygdaloid pERK1/2 in corticotropin-releasing hormone overexpressing mice under basal and acute stress conditions S Silberstein, AM Vogl, D Refojo, SA Senin, W Wurst, F Holsboer, ... Neuroscience 159 (2), 610-617, 2009 | 13 | 2009 |
| Vitamin D3 signalling in the brain enhances the function of phosphoprotein enriched in astrocytes – 15 kD (PEA‐15) D Obradovic, C Zanca, A Vogl, D Trümbach, J Deussing, G Condorelli, ... Journal of Cellular and Molecular Medicine 13 (9b), 3315-3328, 2009 | 7 | 2009 |
| Bis‐ethynylphosphonamidates as an Modular Conjugation Platform to Generate Multi‐Functional Protein‐and Antibody‐Drug‐Conjugates MA Kasper, L Lassak, AM Vogl, I Mai, J Helma, D Schumacher, ... European Journal of Organic Chemistry 2022 (10), e202101389, 2022 | 6 | 2022 |
| chumacher M, von Wolff G D Refojo, M Schweizer, C Kuehne, S Ehrenberg, C Thoeringer, AM Vogl, ... Avrabos C, Touma C, Engblom D, Schutz G, Nave KA, Eder M, Wotjak CT …, 2011 | 3 | 2011 |
| Conditional overexpression of corticotropin-releasing hormone in mice, an animal model for understanding the development of corticotropin-releasing hormone-mediated brain pathology JM Deussing, A Lu, MA Steiner, AM Vogl, F Holsboer, CT Wotjak, W Wurst The International Journal of Neuropsychopharmacology 11, 117, 2008 | 2 | 2008 |
| Tub-010, a novel antibody-drug-conjugate with reduced nonspecific toxicity profile based on tub-tag technology widens the therapeutic window for the treatment of CD30+ Malignancies M Gerlach, S Schmitt, P Cyprys, MA Kasper, I Mai, MH Vermeer, ... Blood 140 (Supplement 1), 9397-9398, 2022 | 1 | 2022 |
| TUB-040, a novel Napi2b-targeting ADC built with ethynylphosphonamidate conjugation chemistry, demonstrates high and long-lasting anti-tumor efficacy via Topoisomerase-I … S Schmitt, I Mai, P Machui, S Herterich, D Hauswald, P Ochtrop, P Cyprys, ... Cancer Research 84 (6_Supplement), 2622-2622, 2024 | | 2024 |
| Enabling 5T4 for targeted cancer therapy: TUB-030, a novel ADC built with ethynylphosphonamidate conjugation chemistry, shows long-lasting anti-tumor activity via Topoisomerase … S Schmitt, I Mai, P Machui, S Herterich, D Hauswald, P Ochtrop, P Cyprys, ... Cancer Research 84 (6_Supplement), 2623-2623, 2024 | | 2024 |
| Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates S Schmitt, P Machui, I Mai, S Herterich, S Wunder, P Cyprys, M Gerlach, ... Molecular Cancer Therapeutics 23 (2), 199-211, 2024 | | 2024 |
| Conjugates comprising a phosphorus (v) and a camptothecin moiety M Kasper, P Machui, MAI Isabelle, V Annette, S Schmitt, D Schumacher, ... US Patent App. 18/054,063, 2023 | | 2023 |
